サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363332

CRRT（持続的腎代替療法）の市場規模、シェア、動向分析レポート：製品別、モダリティ別、地域別、セグメント予測、2023年～2030年

Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (System, Consumables), By Modality, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
CRRT（持続的腎代替療法）の市場規模、シェア、動向分析レポート：製品別、モダリティ別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月27日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

CRRT（持続的腎代替療法）市場の成長と動向：

Grand View Research社の最新レポートによると、世界のCRRT（持続的腎代替療法）市場規模は2030年までに26億380万米ドルに達すると予測されています。

市場は2023年から2030年にかけてCAGR 8.6％で拡大すると予測されます。市場成長の主な促進要因は、うっ血性心不全と急性腎不全の有病率の増加です。COVID-19は、急性腎不全の有病率の増加により、市場にプラスの影響を与えると予想されます。WHOによると、急性腎障害は腎臓が機能しなくなり、尿毒症や体液毒素が体内に蓄積する、生命を脅かす可能性のある状態で、COVID-19の多くの副作用の一つです。その結果、COVID-19の発生が拡大するにつれて、CRRTの需要は上昇し続けると思われます。

予測期間中、技術的進歩が市場成長の重要な原動力になると予想されます。例えば、2020年8月、急性期医療の世界的リーダーであるバクスター・インターナショナル社は、同社の体外循環路局所クエン酸塩抗凝固用クエン酸塩含有交換液Regiocitが米国食品医薬品局（FDA）から緊急使用許可（EUA）を取得したと発表しました。EUAによると、レジオシットは、CRRT（持続的腎代替療法）を受けている成人患者で、COVID-19パンデミック時に局所クエン酸塩抗凝固療法を必要とする患者への補充液としての使用が独占的に承認されています。

CRRT（持続的腎代替療法）市場レポートハイライト

  • 製品別では、消耗品セグメントが2022年に60.6%の最大売上シェアを占めました。これらの製品は低価格であるが、繰り返し購入され使用されるため、消耗品市場は他のセグメントと比較して最大です。
  • モダリティ別では、持続的静脈血液濾過（CVVH）分野が2022年に31.6%の最大売上シェアを占めました。クリティカルケア病棟の急性腎障害患者によく見られる体液過多の状況は増加すると予想され、CVVH市場の成長を後押ししています。
  • CRRT（持続的腎代替療法）市場は、アジア太平洋地域が9.8%の成長率で最も急成長しています。この地域の成長には、技術の進歩、ヘルスケアインフラの発展、巨大な患者基盤の存在など、さまざまな要因が関係しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 CRRT（持続的腎代替療法）市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • CRRT（持続的腎代替療法）市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 CRRT（持続的腎代替療法）市場：製品別推定・動向分析

  • CRRT（持続的腎代替療法）市場：重要なポイント
  • CRRT（持続的腎代替療法）市場：動向と市場シェア分析、2022年および2030年
  • システム
  • 消耗品

第5章 CRRT（持続的腎代替療法）市場：モダリティ別推定・動向分析

  • CRRT（持続的腎代替療法）市場：重要なポイント
  • CRRT（持続的腎代替療法）市場：動向と市場シェア分析、2022年および2030年
  • 低速連続限外濾過（SCUF）
  • 持続的静脈静脈血液濾過（CVVH）
  • 持続的静脈静脈血液透析（CVVHD）
  • 持続的静脈静脈血液透析濾過（CVVHDF）

第6章 CRRT（持続的腎代替療法）市場：地域別推定・動向分析

  • 地域別の展望
  • 地域別のCRRT（持続的腎代替療法）市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要参入企業による最近の開発と影響分析
  • 市場参入企業の分類
    • B. BRAUN MELSUNGEN AG
    • BAXTER INTERNATIONAL, INC.
    • FRESENIUS MEDICAL CARE AG & CO. KGAA
    • ASAHI KASEI CORPORATION
    • NIPRO CORPORATION
    • TORAY MEDICAL CO., LTD.
    • NXSTAGE MEDICAL, INC
    • MEDTRONIC PLC
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 7 Canada continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 9 Europe continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 11 Europe continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 14 UK continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 16 France continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 17 France continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 18 Italy continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 20 Spain continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 22 Sweden continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 23 Sweden continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 24 Norway continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 25 Norway continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 26 Denmark continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 33 China continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 34 China continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 35 India continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 36 India continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 37 Australia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 39 Thailand continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 41 South Korea continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 43 Latin America continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Latin America continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 48 Mexico continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 50 Argentina continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa continuous renal replacement therapy market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 59 UAE continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)
  • Table 61 Kuwait continuous renal replacement therapy market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait continuous renal replacement therapy market, by modality, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Continuous renal replacement therapy: market outlook
  • Fig. 9 Continuous renal replacement therapy competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Continuous renal replacement therapy market driver impact
  • Fig. 15 Continuous renal replacement therapy market restraint impact
  • Fig. 16 Continuous renal replacement therapy market strategic initiatives analysis
  • Fig. 17 Continuous renal replacement therapy market: Product movement analysis
  • Fig. 18 Continuous renal replacement therapy market: Product outlook and key takeaways
  • Fig. 19 System market estimates and forecasts, 2018 - 2030
  • Fig. 20 Consumables market estimates and forecasts, 2018 - 2030
  • Fig. 21 Continuous renal replacement therapy market: Modality class outlook movement analysis
  • Fig. 22 Continuous renal replacement therapy market: Modality class outlook and key takeaways
  • Fig. 23 Slow continuous ultra-filtration market (SCUF) estimates and forecasts, 2018 - 2030
  • Fig. 24 Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 - 2030
  • Fig. 25 Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 - 2030
  • Fig. 26 Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 - 2030
  • Fig. 27 Continuous renal replacement therapy market: Regional movement analysis
  • Fig. 28 Continuous renal replacement therapy market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 31 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 33 UK market estimates and forecasts, 2018 - 2030
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 35 France market estimates and forecasts, 2018 - 2030
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 43 China market estimates and forecasts, 2018 - 2030
  • Fig. 44 India market estimates and forecasts, 2018 - 2030
  • Fig. 45 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-1-68038-607-3

Continuous Renal Replacement Therapy Market Growth & Trends:

The global continuous renal replacement therapy market size is anticipated to reach USD 2,603.8 million by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 8.6% from 2023 to 2030. The primary driving factors for market growth are increasing prevalence of congestive heart failure and acute renal failure. The COVID-19 is expected to have a positive impact on market due to increasing prevalence of acute kidney injury. According to a WHO, acute kidney injury, a potentially life-threatening condition in which the kidneys cease working and uremic and fluid toxins build up in the body, is one of the many COVID-19 side effects. As a result, as the COVID-19 outbreak expands, demand for CRRT will continue to climb.

Over the forecast period, technological advancements are expected to be a crucial driver in the growth of the market. For example, in August 2020, Baxter International Inc., a global leader in acute care, announced that Regiocit, the company's replacement solution containing citrate for extracorporeal circuit regional citrate anticoagulation, has acquired an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA). Regiocit is exclusively approved for use as a replacement solution in adult patients receiving Continuous Renal Replacement Therapy (CRRT) and who require regional citrate anticoagulation during the COVID-19 pandemic, according to the EUA.

Continuous Renal Replacement Therapy Market Report Highlights:

  • By product, the consumables segment held the largest revenue share of 60.6% in 2022. Although these products are low-priced, it is used repeatedly purchased; hence the market for consumables is the largest as compared to other segments
  • Based on the modality, the Continuous Veno-venous Hemofiltration (CVVH) segment held the largest revenue share of 31.6% in 2022. Fluid overload situations, which are common in acute kidney injury patients in critical care units, are expected to increase, boosting the CVVH market's growth
  • Asia Pacific was the fastest growing market for continuous renal replacement therapy with a growth rate of 9.8%. Various factors are responsible for the region growth such as technological advancement, growing healthcare infrastructure development as well as and presence of such a huge patient base in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Modality
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Modality outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Continuous Renal Replacement Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Continuous Renal Replacement Therapy Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis

  • 4.1. Continuous Renal Replacement Therapy Market: Key Takeaways
  • 4.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. System
    • 4.3.1. System market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Continuous Renal Replacement Therapy Market: Modality Class Estimates & Trend Analysis

  • 5.1. Continuous Renal Replacement Therapy Market: Key Takeaways
  • 5.2. Continuous Renal Replacement Therapy Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Slow Continuous Ultra-Filtration (SCUF)
    • 5.3.1. Slow continuous ultra-filtration market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Continuous Venovenous Hemofiltration (CVVH)
    • 5.4.1. Continuous venovenous hemofiltration (CVVH) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.5.1. Continuous venovenous hemodialysis (CVVHD) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Continuous Venovenous Hemodiafiltration (CVVHDF)
    • 5.6.1. Continuous venovenous hemodiafiltration (CVVHDF) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Continuous Renal Replacement Therapy Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. U.K.
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. B. BRAUN MELSUNGEN AG
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. BAXTER INTERNATIONAL, INC.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. FRESENIUS MEDICAL CARE AG & CO. KGAA
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. ASAHI KASEI CORPORATION
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. NIPRO CORPORATION
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. TORAY MEDICAL CO., LTD.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. NXSTAGE MEDICAL, INC
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. MEDTRONIC PLC
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives